Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma

Author: Xue C.   Huang Y.   Huang P. Y.   Yu Q. T.   Pan J. J.   Liu L. Z.   Song X. Q.   Lin S. J.   Wu J. X.   Zhang J. W.   Zhao H. Y.   Xu F.   Liu J. L.   Hu Z. H.   Zhao L. P.   Zhao Y. Y.   Wu X.   Zhang J.   Ma Y. X.   Zhang L.  

Publisher: Oxford University Press

ISSN: 0923-7534

Source: Annals of Oncology, Vol.24, Iss.4, 2013-04, pp. : 1055-1061

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content